tiprankstipranks
Marker Therapeutics provides update on MT-601 patients
PremiumThe FlyMarker Therapeutics provides update on MT-601 patients
2M ago
Marker Therapeutics awarded $9.5M grant from CPRIT
Premium
The Fly
Marker Therapeutics awarded $9.5M grant from CPRIT
2M ago
Marker Therapeutics files $300M mixed securities shelf
Premium
The Fly
Marker Therapeutics files $300M mixed securities shelf
3M ago
Marker Therapeutics awarded $2M grant from NIH SBIR program
PremiumThe FlyMarker Therapeutics awarded $2M grant from NIH SBIR program
6M ago
Marker Therapeutics’ Promising Cancer Therapy Progress
Premium
Company Announcements
Marker Therapeutics’ Promising Cancer Therapy Progress
9M ago
Marker Therapeutics initiated with a Buy at Ladenburg on post-CAR-T opportunity
Premium
The Fly
Marker Therapeutics initiated with a Buy at Ladenburg on post-CAR-T opportunity
10M ago
Marker Therapeutics Ends Stock Sale Deal with LPC
PremiumCompany AnnouncementsMarker Therapeutics Ends Stock Sale Deal with LPC
12M ago
Marker receives approval from the USAN council, INN committee for neldaleucel
Premium
The Fly
Marker receives approval from the USAN council, INN committee for neldaleucel
1y ago
Marker Therapeutics announces clinical program updates, pipeline prioritization
Premium
The Fly
Marker Therapeutics announces clinical program updates, pipeline prioritization
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100